行情

OMCL

OMCL

Omnicell
NASDAQ

实时行情|Nasdaq Last Sale

70.87
+2.99
+4.40%
交易中 15:52 04/08 EDT
开盘
68.78
昨收
67.88
最高
71.30
最低
66.66
成交量
14.21万
成交额
--
52周最高
94.85
52周最低
54.24
市值
30.10亿
市盈率(TTM)
49.80
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测OMCL价格均价为88.14,最高价位105.00,最低价为59.00。

EPS

OMCL 新闻

更多
  • 比尔盖茨:美国“彻底”摆脱新冠疫情要等到明年秋天
  • 新浪美股 · 24分钟前
  • 美联储坚称资产购买“不是QE”还有弹药 市场反应平淡
  • 新浪美股 · 27分钟前
  • 尾盘:美股涨幅扩大 道指涨逾700点
  • 新浪美股 · 52分钟前
  • 美联储会议纪要:经济前景面临“极大程度”不确定性
  • 新浪美股 · 1小时前

所属板块

先进医疗设备和技术
+3.87%
医疗设备和用品
+4.94%

热门股票

代码
价格
涨跌幅

OMCL 简况

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.
展开

微牛提供Omnicell, Inc.(NASDAQ-OMCL)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的OMCL股票新闻,以帮助您做出投资决策。